T uberculosis is one of the major public health problems. About one-third of the world population has been latently infected with Mycobacterium tuberculosis (1) . The tuberculosis incidence is increasing in association with increased numbers of HIV/AIDS patients. Furthermore, the emergency of multidrug-resistant strains of M. tuberculosis has worsened the problems. To prevent an epidemic of tuberculosis, Mycobacterium bovis bacillus Calmette-Guérin (BCG) 3 is the only vaccine currently available against tuberculosis. Although BCG vaccine protect children efficiently against the early manifestations of tuberculosis (2, 3), especially meningeal tuberculosis (4) , it confers incomplete protection against tuberculosis in adults presumably because BCG may not be effective for inducing long-term cellular immunity sufficient for protection against pulmonary disease (5) . Furthermore, BCG, a live vaccine, may not be safe for immunocompromised hosts such as AIDS and aged patients. Therefore, it is urgently required to develop prophylactic and therapeutic vaccines for tuberculosis in place of BCG (6) .
Although protection against infection with intracellular bacteria such as M. tuberculosis depends mainly on CD4 ϩ Th1 cells, there are substantial lines of evidence that CD8 ϩ T cells also play a requisite role (7) (8) (9) . ␤ 2 -microglobulin-deficient mice and TAP-deficient mice, both of which lack functional CD8 ϩ T cells, are susceptible to infection with M. tuberculosis (10, 11) . Adoptive transfer of immunized CD8 ϩ T cells conferred protection against subsequent challenge with M. tuberculosis (12) . Thereafter, various vaccination strategies have settled to efficiently induce protective memory CD8 ϩ T cells. Peptide-pulsed mature bone marrow-derived dendritic cells (BMDC) efficiently generate high numbers of effector and memory CD8 ϩ T cells (13) (14) (15) and there have been several studies on BMDC-based vaccines against M. tuberculosis (16 -18) in which a certain level of protection was observed. However, an obstacle for clinical application of these peptide-based vaccination strategies is the polymorphism of MHC molecules (19) .
Although most of CD8 ϩ T cells recognize peptides on highly polymorphic class Ia molecules, some CD8 ϩ T cells recognize peptides presented by class Ib molecules which have limited polymorphism (20) . H2-M3 is a member of MHC class Ib molecules showing specificity for hydrophobic peptide sequences initiating with N-formyl methionine derived from only bacteria or mitochondrial proteins (21, 22) . Chun et al. (23) have identified M. tuberculosis-derived peptides which bind H2-M3 and showed an involvement of H2-M3-restricted CD8 ϩ T cell response in murine models of M. tuberculosis infection. Thus, H2-M3-binding peptides may serve as a good candidate for universal vaccine against M. tuberculosis (24) . At present, it is unclear whether immunization with H2-M3 peptide induces long-lasting protective immunity to M. tuberculosis infection.
In the present study, we examined the effects of vaccination with BMDC pulsed with a H2-M3-binding peptide, TB2 (23) 
Materials and Methods

Animals
Six-to 8-wk-old female C57BL/6 mice (Charles River Laboratories) and C57BL/6 Ly5.1-congenic mice (The Jackson Laboratory) were used. They were housed in a pathogen-free environment throughout the experiment. This study was approved by the Committee of Ethics on Animal Experiment in Faculty of Medicine (Kyushu University, Kyushu, Japan). Experiments were conducted under the control of the Guidelines for Animal Experiment and were performed mainly under barrier conditions in a level III biosafety animal facility.
Microorganisms
M. tuberculosis strain H37Rv was grown in Middlebrook 7H9 medium (Difco) supplemented with albumin-dextrose-catalase enrichment (Difco) and Tween 80 at 37°C. The bacteria in the culture were stored in Middlebrook 7H9 medium supplemented with 20% (v/v) glycerol at Ϫ80°C until they were used.
Abs and synthetic peptides
Following Abs were used: FITC-conjugated anti-IFN-␥ (R4-6A2), Cy5-conjugated anti-CD8a (53-6.7), PE-conjugated anti-CD44 (IM7), biotinconjugated anti-CD45.1 (A20), and streptavidin-Cy5 (eBioscience). The H2-D b -restricted peptide, MPT64 190 -198 (FAVTNDGVI) (25-27), Mtb32A 309 -318 (GAPINSATAM) (28, 29) , 38 kDa 129 -137 (AQQVNY NLP) (30), the H2-K b -restricted peptide, OVA 257-264 (SIINFEKL), and the H 2 -M 3 -restricted peptide, TB2 (f-MLVLLV), TB4 (f-MFLIDV), TB7 (f-MILLV) (23) , and LemA (f-MIGWII) (Table I) were purchased from Greiner Bio-One.
Generation of peptide-pulsed BMDCs and immunization
RBC-depleted bone marrow cells were cultured at 1 ϫ 10 6 cells/ml in RPMI 1640 medium (Sigma-Aldrich) supplemented with 20 ng/ml murine IL-4 and 20 ng/ml murine GM-CSF (PeproTech) at 37°C with 5% CO 2 . Three days after the initial culture, two-thirds of the medium containing small nonadherent cells were removed and fresh RPMI 1640 containing GM-CSF and IL-4 was added back. At day 6, 1 g/ml LPS (SigmaAldrich) was added to induce maturation. After an overnight culture, 5 M synthetic peptides are added to the cultures 3 h before harvest. The nonadherent cells were harvested and then layered onto 15% metrazimade (Sigma-Aldrich). After a centrifugation at 600 ϫ g for 20 min at 20°C, mononuclear cells at the interface were collected and washed twice before immunization. These cells were 80 -90% CD11c ϩ and expressed high levels of CD80, CD86, CD40 molecules. C57BL/6 mice were injected i.v. with 1 ϫ 10 6 peptide-pulsed BMDC via the dorsal tail vein. Control mice received either PBS or none peptide-pulsed BMDC.
Quantification of Ag-specific CD8
ϩ T cell response
The number of CD8 ϩ T cells specific for MPT64 190 -198 or TB2 was determined by intracellular staining for IFN-␥. The cells were incubated for 5-6 h with or without 5 M of synthetic peptides in the presence of 10 g/ml brefeldin A at 37°C. For the surface staining, cells were first incubated with a mAb directed against the Fc␥ II/III receptors (2.4G2) and were incubated with PE-conjugated anti-CD44 mAb and Cy5-conjugated anti-CD8 mAb. The cells were fixed, permeabilized, and further stained with FITC-conjugated anti-IFN-␥ mAb. Samples were run on a FACSCalibur flow cytometer (BD Biosciences) and analyzed with CellQuest software (BD Biosciences).
Quantification of cytokine by ELISA
CD8
ϩ T cells in the spleens were purified after depleting nylon wooladherent cells by positive selection using anti-CD8 magnetic beads (Miltenyi Biotec). CD8 ϩ T cells (2 ϫ 10 5 ) were cocultured with mitomycin C-treated syngeneic splenocytes (2 ϫ 10 5 ) from naive C57BL/6 mice at a volume of 200 l in the presence or absence of different concentrations of synthetic peptides. The cells were incubated at 37°C and 5% CO 2 for 48 h and culture supernatants were collected and stored at Ϫ20°C. The amount of IFN-␥ and TNF-␣ was measured by ELISA kit (R&D Systems) according to the manufacturer's protocols.
In vivo cytotoxicity assay B6-Ly5.1 ϩ splenocytes were divided and labeled with either a high concentration (5 M) or a low concentration (0.5 M) of CFSE (Invitrogen Life Technologies). CFSE high cells were pulsed with 5 M synthetic peptide for 1 h at 37°C, whereas CFSE low cells left uncoated. After washing, the cells were mixed in equal proportions (2 ϫ 10 7 total cells/200 l) and injected i.v. into mice immunized with peptide-pulsed DC 6 days previously. Splenocytes in the recipients were harvested 4 h later for flow cytometric analysis. Percent-specific lysis was calculated according to the formula (1 Ϫ (ratio primed/ratio unprimed) ϫ 100), where the ratio unprimed ϭ percent CFSE low /percent CFSE high cells remaining in nonimmunized recipients, and ratio primed ϭ percent CFSE low /percent CFSE high cells remaining in immunized recipients.
Infection of immunized mice with M. tuberculosis
Mice were anesthetized by i.p. injection of pentobarbital sodium and tracheae were exposed. Infection was effected by intratracheal inoculation with 1 ϫ 10 5 viable CFU of M. tuberculosis H37Rv diluted in 50 l of PBS. The numbers of viable bacteria in organs were measured 7 or 28 days after infection by plating serial dilutions of whole organ homogenates on supplemented Middlebrook 7H10 agar (Difco) enriched with 10% oleic acid-albumin-dextrose-catalase (Difco) and 0.5% glycerol, and incubated at 37.5°C for 3 wk. Colonies were counted and total tissue CFU calculated.
ELISPOT assay
The numbers of MPT64 190 -198 -or TB2-specific T cells in the lungs and spleen after infection with M. tuberculosis were determined by an ELISPOT assay (Mouse IFN-␥ ELISPOT Set; BD Biosciences) according to the manufacturer's instructions. Lung mononuclear cells were prepared by collagenase digestion and were pooled from three mice. To supplement APCs in the lung cells, mitomycin C-treated syngeneic splenocytes were added at a ratio of 1:1 lung cells/APCs. Two-fold serial dilutions of the 100-l admixture were added in triplicate to the wells precoated with antimouse IFN-␥ mAb starting at 1 ϫ 10 5 lung cells/well. The wells were further added with 100 l of RPMI 1640-FCS containing no Ag, 5 M MPT64 190 -198 or 5 M TB2. After 24 h of incubation at 37°C and 5% CO 2 , unattached cells were aspirated from the wells and the remaining cells were lysed with distilled water. The wells were washed again with PBS containing 0.05% Tween 20 and incubated with a second biotinylated antimouse IFN-␥ mAb. The wells were then washed with PBS-Tween 20, incubated for 1 h with streptavidin-HRP, washed, and developed with 3-amino-9-ethyl-carbazol as substrate. After washing and drying, the number of spots per well was counted with the aid of a digital microscope at ϫ40. The number of cells specific for each peptide was calculated by subtracting the number of spots formed in the absence of Ag from that formed in its presence. Experiments were repeated twice.
Histopathology
Tissues were preserved in 10% buffered formalin, embedded in paraffin, sectioned, and stained with H&E. Random sections including hilar of the lung from five mice per group were examined. 
Statistical analysis
The statistical significance of the bacteria number was determined by oneway ANOVA. Other data were determined by the Student t test. Differences with a p value of Ͻ0.05 were considered significant. Analyses were completed using SPSS software.
Results
Induction of MHC class Ia-and H2-M3-restricted CD8 ϩ T cell expansion by peptide-pulsed BMDCs
Chun et al. (23) have identified several M. tuberculosis-derived peptides binding to a MHC class Ib molecule, H2-M3. We first compared immunogenicity of three of these peptides named TB2, TB4, and TB7 (Table I ), all of which were shown to be immunogenic in M. tuberculosis-infected C57BL/6 mice (23). We examined expansion of Ag-specific T cells after immunization with peptide-pulsed BMDC, which were treated with LPS to induce full maturation. We found this maturation step was necessary for inducing clear expansion of Ag-specific T cells in preliminary experiments (data not shown). As shown in Fig. 1A , an expansion of CD8 ϩ T cells producing IFN-␥ was observed 6 days after immunization with H2-M3-binding peptides. Among the peptides tested, TB2 induced the strongest expansion of Ag-specific T cells. We also tested three MHC class Ia-restricted peptides derived from M. tuberculosis (Table I) for their immunogenicity. Although MPT64 190 -198 gave a strong T cell response similar to the control OVA, the other two M. tuberculosis-derived peptides induced only marginal expansion of Ag-specific T cells. Therefore, we used TB2 and MPT64 190 -198 as representative of H2-M3-binding and MHC class Ia-binding peptides, respectively, in the subsequent experiments. It is of note to find that, mean fluorescent intensity (MFI) for IFN-␥ staining of MPT64 190 -198 -specific CD8 ϩ T cells was higher than that of TB2-specific CD8 ϩ T cells at any concentration of the peptides (Fig. 1, B and C) . Furthermore, CD8
ϩ T cells specific for MHC class Ia-restricted peptides generally showed higher MFI than those specific for H2-M3-binding peptide (average MFI 77.8 vs 55.0, respectively, p ϭ 0.007) (Fig. 1D) .
Kinetic analysis revealed that the number of MPT64 190 -198 -or TB2-specific CD8 ϩ T cells in the spleen and the lung peaked on day 6 after immunization and contracted until day 20, and then was maintained an appreciable level at least 60 days (Fig. 2) . The absolute number of TB2-specific CD8 ϩ T cells tended to be higher than that of MPT64 190 -198 -specific CD8 ϩ T cells in the spleen at the peak, but there were no significant differences. Although the number of TB2-specific CD8 ϩ T cells was lower than that of MPT64 190 -198 -specific CD8 ϩ T cells at day 60, it was still above background. These data showed that not only MHC class Ia-restricted MPT64 190 -198 -but also H2-M3-restricted TB2-pulsed mature BMDC induced long-lasting Ag-specific CD8 ϩ T cells.
Effector functions of TB2-and MPT64-specific CD8 ϩ T cells
As potential of IFN-␥ production seemed different between MHC class Ia-and H2-M3-restricted CD8 ϩ T cells by intracellular flow cytometric analysis (Fig. 1, B-D) , we further compared the functions of TB2-specific CD8 ϩ T cells and MPT64 190 -198 -specific CD8 ϩ T cells 6 days after immunization. IFN-␥ and TNF-␣ production by spleen CD8 ϩ T cells were measured by ELISA. Although there was no significant difference between the number of TB2-specific CD8 ϩ T cells and that of MPT64 190 -198 -specific CD8 ϩ T cells in the spleen as shown in Fig. 2 , TB2-specific CD8 ϩ T cells produced less IFN-␥ than MPT64 190 -198 -specific CD8 ϩ T cells at any concentration of the peptide (Fig. 3A) . The level of TNF-␣ production was also lower in TB2-specific CD8 ϩ T cells than MPT64 190 -198 -specific CD8 ϩ T cells (Fig. 3B ). We next evaluated the cytotoxic activity of MPT64 190 -198 -or TB2-specific CD8 ϩ T cells by measuring in vivo cytotoxic activity against syngeneic peptide-pulsed splenocytes 6 days after immunization. Both MPT64 190 -198 -specific CD8 ϩ T cells and TB2-specific CD8 ϩ T cells lysed peptide-pulsed syngeneic splenocytes (Fig. 4) . As opposed to the case of IFN-␥ or TNF-␣ production, the cytotoxic activity of TB2-specific CD8 ϩ T cells was significantly higher than that of MPT64 190 -198 -specific CD8 ϩ T cells. Taken together, these data indicated that, although H2-M3-restricted TB2-specific CD8 ϩ T cells and MHC class Ia-restricted MPT64 190 -198 -specific CD8 ϩ T cells expand in similar extent with similar time kinetics after immunization with BMDC, they have somewhat different activities of function.
Response of MPT64 190 -198 -or TB2-specific CD8 ϩ T cells during infection with M. tuberculosis
To examine whether CD8 ϩ T cell response to MPT64 190 -198 or TB2 was elicited during infection with M. tuberculosis, the number of MPT64 190 -198 -or TB2-specific T cells in the lung or spleen from 2 ϫ 10 2 CFU M. tuberculosis H37Rv-infected mice was measured by an ELISPOT assay (Fig. 5) . Two weeks after infection, a small number of peptide-specific IFN-␥ spots was detected in the lung and the spleen. The frequency of MPT64 190 -198 -and TB2-specific CD8 ϩ T cells both rapidly increased from 3 wk after infection then reached a peak at 4 wk after infection. These results clearly indicate that MPT64 190 -198 and TB2 are presented during M. tuberculosis infection. There was no clear difference in kinetics of the response between MPT64 190 -198 -and TB2-specific CD8 ϩ T cells.
H2-M3-restricted TB2-specific CD8 ϩ T cells protect mice from intratracheal M. tuberculosis infection
To examine whether these CD8 ϩ T cells are both protective against M. tuberculosis, we challenged the mice intratracheally with M. tuberculosis H37Rv 6 days after immunization with MPT64 190 -198 -pulsed BMDC (DC-MPT64), TB2-pulsed BMDC (DC-TB2), or BMDC without peptides (DC-NONE) (Fig. 6A) . One or 4 wk after infection, lungs and spleens were prepared from the mice and the extent of bacterial growth was determined. At 1 wk, the CFU in the lung of DC-TB2-immunized mice tended to be lower than those of DC-NONE-immunized mice or naive mice, but it was not statistically significant. At 4 wk, the CFU in these organs of DC-MPT64 or DC-TB2 immunized mice was significantly lower than that of DC-NONE-immunized mice or naive mice. The difference of the CFU in the lung was ϳ1 log10 order. Thus, both MPT64 190 -198 -specific CD8 ϩ T cells and TB2 specific-CD8 ϩ T cells were protective against respiratory M. tuberculosis infection.
Vaccination with TB2-pulsed BMDC conferred long-lasting protective immunity against M. tuberculosis
As shown in Fig. 2, MPT64 190 -198 -specific CD8 ϩ T cells and TB2-specific CD8 ϩ T cells were maintained for 60 days after immunization. To evaluate whether BMDC immunization can induce long-lasting protective immunity against M. tuberculosis, we challenged intratracheally with M. tuberculosis 60 days later after immunization. At 4 wk, the CFU in the lungs of DC-MPT64-or DC-TB2-immunized mice was significantly lower than those of DC-NONE-immunized mice and naive mice (Fig. 6B) . The difference of the CFU in the lungs was ϳ1 log 10 order. Although the CFU in the spleens was considerably lower than that of DC-NONE-immunized mice or naive mice, there was no statistical difference. These data suggested that both MHC class Ia-restricted CD8 ϩ T cells and H2-M3-restricted CD8 ϩ T cells induced by peptide-pulsed mature BMDC elicited long-lasting protection against respiratory M. tuberculosis infection.
Lung histopathology of the mice immunized with TB2 or MPT64 190 -198 after intratracheal M. tuberculosis infection
As we observed some differences in the activity of function between MPT64 190 -198 -and TB2-specific CD8 ϩ T cells in vivo as well as in vitro (Figs. 3 and 4) , it is of interest to compare histopathological changes in the lungs of the mice immunized with the different peptides. DC-MPT64-immunized mice had larger pulmonary infiltrates composed of formed macrophages (Fig. 7, B and E) compared with control (Fig. 7, A and D) or DC-TB2-immunized mice (Fig. 7, C and F) . Areas of bronchopneumonia were clearly evident and frankly necrotic areas were observed in part (Fig. 7B) . In contrast, although large infiltrates were also observed in the lungs of DC-TB2-immunized mice, there were few necroses and the structure of the walls of the alveoli comparatively avoided destruction (Fig. 7C) . There tended to be greater numbers of lymphocytes in the inflammatory infiltrate compared with DC-MPT64-immunized mice. Both perivascular and interstitial lymphoid infiltrates were observed (Fig. 7F) . These histopathological features suggest that the protection mechanism of TB2-specific
CD8
ϩ T cells against M. tuberculosis infection is different from that of MPT64 190 -198 -specific CD8 ϩ T cells.
Discussion
Because CD8 ϩ T cells play a requisite role in the resistance to mycobacterial infection, Ag-specific CD8 ϩ T cells are major target for vaccine design for tuberculosis. We here showed the first evidence that immunization with mature BMDC pulsed with either MHC class Ia (H-2D b ) binding MPT64 190 -198 or class Ib (H2-M3) binding TB2 peptide induced long-lasting Ag-specific CD8 ϩ T cells and conferred protection against an intratracheal challenge with M. tuberculosis.
There have been several studies on BMDC-based vaccination against M. tuberculosis infection models in mice (16 -18) . McShane et al. (18) reported that mice immunized with immature BMDC pulsed with either MHC class I-or MHC class II-restricted Ag85A peptide was not protective against M. tuberculosis challenge. Nakano et al. (16) reported that retroviral Ag85A gene-transduced, incompletely matured BMDC immunization was not effective enough in terms of clearance of M. tuberculosis from the tissues. In contrast, Malowany et al. (17) reported that adenoviral Ag85A gene-transduced mature BMDC induced much longer immune response compare with immature peptide-pulsed BMDC. These findings clearly indicated the importance of maturational stage of BMDC for vaccination. We also observed a clear difference in inducing T cell response between immature and mature BMDC (data not shown). Thereafter, we used LPS-stimulated BMDC for immunization and successfully induced protective CD8 ϩ T cell responses against M. tuberculosis infection.
There ϩ T cell responses to some of these peptides including TB2 after infection with M. tuberculosis, it has been unknown whether the H2-M3-restricted CD8 ϩ T cells are protective against M. tuberculosis infection. Dow et al. (31) also identified several H2-M3-binding peptides derived from M. tuberculosis and showed CTL response to these peptides. They also examined protection against M. tuberculosis challenged 10 days after immunization with some of these peptides. However, these peptides were longer than the predicted length of H2-M3-binding peptides revealed by the crystallography (32) and also by bioassays (33) , and none of these peptides were identical with the peptides identified by Chun et al. (23) . In this study, we found TB2 elicited strongest T cell response after immunization with peptide-pulsed BMDC. Thereafter, we used TB2 and found that immunization with TB2 confers significant protection as vaccine against M. tuberculosis challenged even 60 days after immunization.
The importance of H2-M3-restricted CD8 ϩ T cells has been more clearly shown in Listeria monocytogenes infection. It was recently reported that H2-M3-deficient mice were impaired in early bacterial clearance during primary L. monocytogenes infection (34) . H2-M3-restricted CD8 ϩ T cells play a role in early protection against a primary L. monocytogenes infection by expanding quicker than class Ia-restricted CD8 ϩ T cells (35, 36) . In the present study, however, we did not find difference in the kinetics of expansion between H2-M3-restricted CD8 ϩ T cells and MHC class Ia-restricted CD8 ϩ T cells either after immunization with BMDC or during M. tuberculosis infection. In the former case, the discrepancy between the previous observations and our findings may be explained by different efficacy in Ag processing between MHC class Ia-binding peptides and H2-M3-binding peptides. For the presentation by MHC class Ia molecules, antigenic peptides in the cytosol are translocated to the lumen of the endoplasmic reticulum by TAP and loaded onto peptide-receptive MHC class Ia complexes. Stably conformed and peptide-filled class Ia complexes then egress from the endoplasmic reticulum to the cell surface. In contrast, TAP did not appear to be absolutely necessary for the presentation of N-formylated peptides by H2-M3 molecules (37) . In addition, the supply of endogenous N-formylated mitochondrial peptides is limited and a significant pool of H2-M3 exists intracellularly, which can be rapidly mobilized to the surface when provided with appropriate exogenous N-formylated peptides (38) . Therefore, it is suggested that MHC class Ib-binding Ag peptides are more rapidly presented by APCs. Immunization with peptide-pulsed mature BMDC may circumvent these time-dependent factors. In the case of in vivo infection, one of the major differences between L. monocytogenes and M. tuberculosis is their growth rate. M. tuberculosis divide slowly and their Ags are presented gradually with time, which may conceal the lag of response of MHC class Ia-restricted CD8 ϩ T cells behind that of H2-M3-restricted CD8 ϩ T cells. Additionally, there seems to be a difference in Ag processing between L. monocytogenes and M. tuberculosis. In contrast to L. monocytogenes, which actively escapes phagosomes and enters the cytosol, M. tuberculosis resides within phagosomes which has features similar to those of an early endosome (39, 40) . Nevertheless, M. tuberculosis-derived peptides are cross-presented by MHC class I pathway, which is supposed to be far less efficient than the case of L. monocytogenes. These differences in Ag processing and presentation of different microbes may also be involved in the discrepancy.
There were some differences in the activities of effector functions between H2-M3-restricted TB2-specific CD8 ϩ T cells and MHC class Ia-restricted MPT64 190 -198 -specific CD8 ϩ T cells, although both were protective against M. tuberculosis infection. Cytotoxic activity of TB2-specific CD8 ϩ T cells was higher than that of MPT64 190 -198 -specific CD8 ϩ T cells, whereas the ability to produce IFN-␥ or TNF-␣ was the opposite. Such differences are usually observed after immunization with different peptides, even restricted by the same MHC molecule and could be related to the stability of the MHC complexes. In this regard, it is notable to find that the expression levels of IFN-␥ were generally lower in H2-M3-restricted CD8 ϩ T cells than in MHC class Ia-restricted CD8 ϩ T cells by intracellular flow cytometric analysis (Fig. 1D) , suggesting that the difference in the activities of function between TB2-and MPT64 190 -198 -specific CD8 ϩ T cells may be generalized to difference between MHC class Ia-and MHC class Ib-restricted CD8 ϩ T cells. Further detailed analysis is needed to test this possibility. These differences in activities of function of CD8 ϩ T cells might result in the different histopathology of the lung between MPT64 190 -198 -and TB2-immunized mice. The lungs of MPT64 190 -198 -pulsed BMDC-immunized mice following M. tuberculosis infection had large pulmonary infiltrates composed of formed macrophages. In contrast, the lungs of TB2-pulsed BMDCimmunized mice following M. tuberculosis infection had less necrosis and reduced pulmonary injury.
In conclusion, our results clearly indicated that vaccination with mature BMDC pulsed with a H2-M3-binding peptide significantly confers protection against M. tuberculosis. Because MHC class Ib molecules including H2-M3 have an advantage of limited polymorphism, immunization with MHC class Ib-restricted peptides would be a novel vaccination strategy against M. tuberculosis infection for a broad range of recipients.
